The store will not work correctly when cookies are disabled.
3-(Biphenyl-3-yl)-2-tert-butyl-6-(thien-3-yl)imidazo[1,2-a]pyridine
ID: ALA2393021
PubChem CID: 71699384
Max Phase: Preclinical
Molecular Formula: C27H24N2S
Molecular Weight: 408.57
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1nc2ccc(-c3ccsc3)cn2c1-c1cccc(-c2ccccc2)c1
Standard InChI: InChI=1S/C27H24N2S/c1-27(2,3)26-25(21-11-7-10-20(16-21)19-8-5-4-6-9-19)29-17-22(12-13-24(29)28-26)23-14-15-30-18-23/h4-18H,1-3H3
Standard InChI Key: LNUIYSJUTYSLPH-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
25.6122 -20.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6110 -21.6290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3191 -22.0379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3173 -20.4006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0259 -20.8058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0261 -21.6290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8091 -21.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2928 -21.2170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8087 -20.5513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0614 -22.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5131 -23.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7652 -24.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5654 -24.2116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1129 -23.5993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8578 -22.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9057 -22.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1594 -21.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6121 -22.3142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0202 -23.0223 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.8196 -22.8529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9122 -23.7647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1668 -24.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9659 -24.7094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5114 -24.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2521 -23.3203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4535 -23.1569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1100 -21.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5189 -21.9243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5184 -20.5089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9265 -21.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 16 2 0
2 16 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
14 21 1 0
8 27 1 0
27 28 1 0
27 29 1 0
27 30 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 408.57 | Molecular Weight (Monoisotopic): 408.1660 | AlogP: 7.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 17.30 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.58 | CX LogP: 7.33 | CX LogD: 7.33 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.30 | Np Likeness Score: -1.39 |
References
1. Enguehard-Gueiffier C, Musiu S, Henry N, Véron JB, Mavel S, Neyts J, Leyssen P, Paeshuyse J, Gueiffier A.. (2013) 3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors., 64 [PMID:23665801] [10.1016/j.ejmech.2013.03.054] |